Coya Therapeutics, Inc. (COYA) vs Foghorn Therapeutics Inc. (FHTX)
A side-by-side comparison of Coya Therapeutics, Inc. and Foghorn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.98HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
FHTX
Foghorn Therapeutics Inc.
$1.95HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — COYA vs FHTX
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)FHTX -64.4% (-22.8%/yr)COYA compounded faster over this window
COYA FHTX
COYA vs FHTX: by the numbers
- •COYA is the larger company ($117M vs $114M market cap).
- •Both run net losses; FHTX's is the smaller (-175.78% vs -270.22% net margin).
Metrics side by side
Valuation
| Metric | COYA | FHTX |
|---|---|---|
| P/S ratio | 14.57 | 3.11 |
| P/B ratio | 0.00 | N/A |
Profitability
| Metric | COYA | FHTX |
|---|---|---|
| Gross margin | 99.91% | 89.22% |
| Operating margin | -255.05% | -265.64% |
| Net margin | -270.22% | -175.78% |
| ROE | -0.05% | N/A |
| ROIC | -0.05% | -44.81% |
Growth (annualized)
| Metric | COYA | FHTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.83% |
| Total return CAGR (5Y) | N/A | -31.87% |
Go deeper
Dig into the metrics
Coya Therapeutics ROEFoghorn Therapeutics ROECoya Therapeutics operating marginFoghorn Therapeutics operating marginCoya Therapeutics revenue growthFoghorn Therapeutics revenue growthCoya Therapeutics free cash flowFoghorn Therapeutics free cash flow
Coya Therapeutics & Foghorn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.